Suppr超能文献

血浆 D-二聚体水平升高是瓦尔登斯特伦巨球蛋白血症患者的预后不良因素。

High plasma D-dimer level is a poor prognostic factor for patients with waldenström macroglobulinemia.

机构信息

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.

Key Laboratory of Hematology of Nanjing Medical University, Nanjing, China.

出版信息

Leuk Lymphoma. 2020 May;61(5):1140-1146. doi: 10.1080/10428194.2019.1709837. Epub 2020 Jan 13.

Abstract

Waldenström Macroglobulinemia (WM) is a rare form of non-Hodgkin lymphoma with great heterogeneity, and data on the role of D-dimer in the progression of WM are limited. We retrospectively searched medical records for 110 newly diagnosed WM patients who were admitted to the department of hematology of the First Affiliated Hospital of Nanjing Medical University from January 2009 to December 2018. Univariate and multivariate analyses were used to assess prognostic factors for overall survival (OS) and progression-free survival (PFS). Characteristics associated with elevated D-dimer level in WM patients were high serum beta-2 macroglobulin, elevated serum lactic dehydrogenase, cytogenetic abnormalities and late stage of the international stage system of WM. Patients with D-dimer >0.55 mg/L had worse OS and PFS. In conclusion, high level of D-dimer was associated with poor survival and acted as a negative predictor for untreated WM patients.

摘要

华氏巨球蛋白血症(WM)是一种罕见的非霍奇金淋巴瘤,具有很大的异质性,关于 D-二聚体在 WM 进展中的作用的数据有限。我们回顾性地检索了 2009 年 1 月至 2018 年 12 月期间在南京医科大学第一附属医院血液科就诊的 110 例新诊断的 WM 患者的病历。采用单因素和多因素分析评估总生存期(OS)和无进展生存期(PFS)的预后因素。与 WM 患者 D-二聚体升高相关的特征包括血清β-2 微球蛋白升高、血清乳酸脱氢酶升高、细胞遗传学异常和 WM 国际分期系统的晚期。D-二聚体>0.55mg/L 的患者 OS 和 PFS 更差。总之,高水平的 D-二聚体与不良生存相关,是未经治疗的 WM 患者的负面预测因子。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验